GlassScriptPhysician profile
Renee C Whelan
NPI 1285618355
$5,634.65
in general payments reported to CMS, 2019-2025
23 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,831 · 2020: $349 · 2021: $676 · 2022: $446 · 2023: $879 · 2024: $442 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,309 · Entertainment: $22.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,309.04 |
| Entertainment | $22.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,669.26 | 2019-2025 | Precision7, Rhopressa, Rocklatan |
| Coopervision INC. | $598.61 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $432.69 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $369.38 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $248.56 | 2021 | |
| Allergan, INC. | $197.75 | 2020-2022 | |
| Oyster Point Pharma, INC. | $136.03 | 2023-2024 | Tyrvaya |
| Glaukos Corporation | $132.19 | 2021-2024 | Radius |
| Regeneron Healthcare Solutions, INC. | $117.72 | 2020 | |
| Hoffmann-La Roche Limited | $104.82 | 2019 | |
| Novartis Pharmaceuticals Corporation | $103.53 | 2019-2023 | |
| Abb Con-Cise Optical Group LLC | $100.19 | 2023 | Contact Lens, Spectacle Lenses |
| Johnson & Johnson Vision Care, INC. | $79.45 | 2019-2024 | |
| Tarsus Pharmaceuticals, INC. | $63.95 | 2025 | Xdemvy |
| Alcon Research LLC | $57.02 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $49.11 | 2019-2025 | |
| Lkc Technologies, INC. | $37.97 | 2025 | |
| Topcon Healthcare, INC. | $32.56 | 2021 | |
| Abbvie INC. | $22.98 | 2022 | |
| Optos, INC. | $22.43 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $19.68 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $19.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Whelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.